ATG induction therapy and the incidence of bronchiolitis obliterans after lung transplantation: Does it make a difference?

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1517-1518

  Wiebe, K ^a   Harringer, W ^a   Wahlers, T ^a   Franke, U ^a   Struber M ^a   Hamm, M ^a   Cremer, J ^a   Haverich, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; THYMOCYTE ANTIBODY;

BRONCHIOLITIS; CONFERENCE PAPER; DRUG EFFICACY; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ANTILYMPHOCYTE SERUM; BRONCHIOLITIS OBLITERANS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0031804212     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00340-6     Document Type: Conference Paper

References (7)

1. Kriett JM, Smith CM, Hayden AM, et al: J Heart Lung Transplant 12:915, 1993
2. Ross DJ, Jordan SC, Nathan SD, et al: Chest 109:870, 1996
3. Bonnefoy-Berard N, Revillard JP: J Heart Lung Transplant 15:435, 1996
4. Cooper JD, Billingham M, Egan T: J Heart Lung Transplant 12:713, 1993
5. Shield CF, Edwards EB, Davies DB, et al: Transplantation 63:1257, 1997
6. Griffith BP, Kormos RL, Armitage JM, et al: J Heart Transplant 9:301, 1990
7. Griffith BP, Hardesty RL, Armitage JM, et al: Ann Thorac Surg 54:846, 1992